Seeking Alpha

Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA...

Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA +0.7%). The firm says it's not concerned with recent headlines and believes organic growth estimates will prove conservative. The firm rates the shares at Outperform with a $12 price target.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|